Proviva Therapeutics
PrivateLast Round
Series A
Feb 1, 2023
Total Funding Raised
$48M
Company Overview
Proviva Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in February 2023.
Proviva Therapeutics is a biotechnology company that develops a pharmaceutical technology platform intended for anti-tumor immunity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proviva Therapeutics Comparables
Compare Proviva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AskGene Pharma | 83% | |
| Asher Biotherapeutics | 82% | |
| Aulos Bioscience | 81% |
For institutional investors. Book with your work email.
Proviva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 1, 2023 | ||||
| Series A Extension | Dec 1, 2022 |
For institutional investors. Book with your work email.
Proviva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A Extension |
| Ennovation Ventures | Series A |
| HongShan Capital Group (HSG) | Series A Extension |
Proviva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proviva Therapeutics's valuation, stock price, and market status.
Is Proviva Therapeutics a public or private company?
Proviva Therapeutics is a private company.
What is the current stock price of Proviva Therapeutics?
Proviva Therapeutics is a private company, so its shares have no public market price. Caplight tracks Proviva Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proviva Therapeutics worth (valuation)?
Valuation information for Proviva Therapeutics is not publicly available.
Can I buy Proviva Therapeutics stock?
Proviva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proviva Therapeutics's last funding round?
Proviva Therapeutics's most recent funding round was Series A on February 1, 2023.
Who are the main investors in Proviva Therapeutics?
Key investors in Proviva Therapeutics include OrbiMed.
Will Proviva Therapeutics IPO soon?
No public IPO plans have been announced for Proviva Therapeutics.
How can I track Proviva Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Proviva Therapeutics's shares on secondary markets.